First half of 2012: Dräger records stable business development
(Thomson Reuters ONE) -
Drägerwerk AG & Co. KGaA /
First half of 2012: Dräger records stable business development
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* Order intake and net sales have grown and remain stable net of currency
effects
* Investments in the Group's future have been further increased
* Outlook confirmed
Lübeck - Drägerwerk AG & Co. KGaA further increased order intake (+2.7 percent)
and net sales (+3.8 percent) in the first half of 2012, thereby profiting from
the weak euro. Net of currency effects, both order intake and net sales were
only slightly up year-on-year.
Order intake went up by 0.1 percent (net of currency effects) to EUR 1,139.1
million in the first six months of 2012 (6 months 2011: EUR 1,109.1 million). A
slight rise in Medical was faced by a drop in Safety. Net sales at Dräger
increased by 0.8 percent (net of currency effects) to EUR 1,072.7 million in the
first half of 2012 (6 months 2011: EUR 1,033.3 million). Both divisions
contributed to this development.
In the second quarter of 2012, Dräger increased order intake by 2.5 percent (net
of currency effects). While Medical saw a significant increase, Safety recorded
a slight decrease. Net sales declined by 1.8 percent (net of currency effects)
in the second quarter, with both divisions contributing to this drop.
Dräger invests in its future
In the first half of 2012, gross profit went up by EUR 24.0 million to EUR
537.7 million, slightly above average compared to net sales. The gross margin
was 50.1 percent, 0.4 percentage points up on the prior year.
In the first half of 2012, functional costs rose by 6.1 percent compared to the
prior-year figure, the main reason being a rise in research and development
(R&D) costs of 22.7 percent. R&D as a percentage of net sales reached 8.7
percent (6 months 2011: 7.4 percent).
Overall, Dräger generated Group earnings before interest and taxes (EBIT) of EUR
93.7 million (6 months 2011: EUR 94.5 million). The EBIT margin amounted to 8.7
percent (6 months 2011: 9.1 percent).
"It comes as no surprise that we did not manage to increase our figures year-on-
year, as we significantly upped our investments in research and development in
the first half of the year, as previously announced, and also increased our IT
investments," commented Stefan Dräger, Chairman of the Executive Board of
Drägerwerk Verwaltungs AG. "We believe that this is the right path to take as
our efforts today will secure our competitive advantage in the future," he
added.
Earnings after income taxes amounted to EUR 53.1 million, down 1.1 percent on
the prior-year period (6 months 2011: EUR 53.7 million). Earnings per share,
based on the financial statements for the first half of 2012, went up year-on-
year.
Outlook confirmed
Dräger continues to expect order intake and net sales to grow at least at the
pace of global economic growth overall (IMF forecast from July 16, 2012: +3.5
percent), despite order intake and net sales (net of currency effects) not
matching global economic growth in the first half of 2012.
Dräger anticipates research and development as well as IT costs, both higher
than originally forecast, will be offset by a slightly improved gross margin.
Overall, Dräger continues to expect a Group EBIT margin between 8.0 percent and
9.5 percent for fiscal year 2012 (2011: 9.5 percent).
The 2013 forecast also remains unchanged.
Key figures for the first six months of 2012 (? million)
+---------------+----------+----------+----------+----------+-------+----------+
| | Second | Second |Six months|Six months|Change | Net of |
| | quarter | quarter | 2012 | 2011 | | currency |
| | 2012 | 2011 | | | | effects |
+---------------+----------+----------+----------+----------+-------+----------+
|Order intake | 588.4| 555.5| 1,139.3| 1,109.1|+ 2.7 %| + 0.1 %|
+---------------+----------+----------+----------+----------+-------+----------+
|Medical | | | | | | |
|division | 387.1| 356.7| 735.7| 713.9|+ 3.1 %| + 0.5 %|
+---------------+----------+----------+----------+----------+-------+----------+
|Safety division| 209.6| 206.2| 419.5| 410.2|+ 2.3 %| - 0.5 %|
+---------------+----------+----------+----------+----------+-------+----------+
| | | | | | | |
+---------------+----------+----------+----------+----------+-------+----------+
|Net sales | 543.4| 533.1| 1,072.7| 1,033.3|+ 3.8 %| + 0.8 %|
+---------------+----------+----------+----------+----------+-------+----------+
|Medical | | | | | | |
|division | 348.0| 341.4| 685.7| 663.0|+ 3.4 %| + 0.4 %|
+---------------+----------+----------+----------+----------+-------+----------+
|Safety division| 202.9| 199.2| 402.4| 385.2|+ 4.5 %| + 1.7 %|
+---------------+----------+----------+----------+----------+-------+----------+
| | | | | | | |
+---------------+----------+----------+----------+----------+-------+----------+
|EBIT | 47.0| 51.9| 93.7| 94.5| | |
+---------------+----------+----------+----------+----------+-------+----------+
|Medical | | | | | | |
|division | 32.2| 39.3| 60.3| 69.9| | |
+---------------+----------+----------+----------+----------+-------+----------+
|Safety division| 24.8| 24.2| 52.3| 45.8| | |
+---------------+----------+----------+----------+----------+-------+----------+
| | | | | | | |
+---------------+----------+----------+----------+----------+-------+----------+
|EBIT margin | 8.6 %| 9.7 %| 8.7 %| 9.1 %| | |
+---------------+----------+----------+----------+----------+-------+----------+
|Earnings after | | | | | | |
|income taxes | 27.7| 30.4| 53.1| 53.7| | |
+---------------+----------+----------+----------+----------+-------+----------+
|EPS preferred | | | | | | |
|share[1] in ? | 1.58| 1.60| 3.06| 2.82| | |
+---------------+----------+----------+----------+----------+-------+----------+
|EPS common | | | | | | |
|share[1] in ? | 1.57| 1.59| 3.03| 2.79| | |
+---------------+----------+----------+----------+----------+-------+----------+
|EPS preferred | | | | | | |
|share[2] in ? | | | | | | |
|Full | | | | | | |
|distribution | 1.21| 1.14| 2.33| 2.02| | |
+---------------+----------+----------+----------+----------+-------+----------+
|EPS common | | | | | | |
|share[2] in ? | | | | | | |
|Full | | | | | | |
|distribution | 1.20| 1.13| 2.30| 1.99| | |
+---------------+----------+----------+----------+----------+-------+----------+
[1] On the basis of the expected dividend
[2] Based on an imputed actual full distribution of earnings attributable to
shareholders
Disclaimer
This press release contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current expectations,
presumptions, and forecasts of the Executive Board as well as the information
available to it to date and have been prepared to the best of its knowledge and
belief. No guarantee or liability for the occurrence of the future developments
and results specified can be assumed in respect of such forward-looking
statements. Rather, the future developments and results are dependent on a
number of factors. They entail risks and uncertainties beyond the Company's
control and are based on assumptions which could prove to be incorrect.
Notwithstanding any legal requirements to adjust forecasts, Dräger does not
assume any obligation to update the forward-looking statements contained in this
report. You will find all important financial dates on our Company website at
www.draeger.com under Investor Center/Financial Calendar.
Contact
Corporate Communications:
Melanie Kamann
Phone: +49 451 882-3998
melanie.kamann(at)draeger.com
Investor Relations:
Thomas Fischler
Phone: +49 451 882-2685
thomas.fischler(at)draeger.com
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Germany
www.draeger.com
Press release (PDF):
http://hugin.info/135701/R/1631256/522909.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Drägerwerk AG & Co. KGaA via Thomson Reuters ONE
[HUG#1631256]
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2012 - 07:30 Uhr
Sprache: Deutsch
News-ID 170996
Anzahl Zeichen: 10827
contact information:
Town:
Lübeck
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 258 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"First half of 2012: Dräger records stable business development"
steht unter der journalistisch-redaktionellen Verantwortung von
Drägerwerk AG & Co. KGaA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
